U.S., Oct. 8 -- ClinicalTrials.gov registry received information related to the study (NCT07209722) titled 'PrEP4Her: Developing a Novel Strategy to Implement PrEP Into Women's Healthcare' on Sept. 29.
Brief Summary: The purpose of the study is to learn more about health care providers' experiences and perspectives on prescribing HIV pre-exposure prophylaxis, also known as PrEP. Providers and patients in gynecology clinics were interviewed and completed surveys to measure the feasibility and preference of prescribing PrEP.
Study Start Date: Sept. 22, 2023
Study Type: OBSERVATIONAL
Condition:
PrEP Precriptions for Reproductive Aged Women
Intervention:
BEHAVIORAL: PrEP acronym (pre-exposure prophylaxis)
Tracked PrEP prescriptions over...